Sitagliptin clinical trials antidiabetic drugs

MK-0431 - MK0431 - MK 0431 - Januvia - sitagliptin phosphate - sitagliptin

Diabetes type 2

All type of patients:   pinterest powerpoint 10158,10170,10159,13378,10160,13379,10161,10171,10162,13376,10163,13365,10164,13366,10165,13367,10166,13368,13369,13370,10167,13371,10168,13372,13373,10169,13374,13375,13377

All types of patients:   pinterest powerpoint 10159,10160,10161,10162,10163,10164,10165,13369,13377,10166,10167,13366,10168,13378,13370,10169,13379,10170,10158,13371,13372,13365,13373,13368,13374,10171,13375,13367,13376

Patients inadequately controlled on metformin:   pinterest powerpoint 10166,10169,10171

Patients inadequately controlled on monotherapy :   pinterest powerpoint 10166,10169,10170,10171

Patients with insufficient glycaemic control with bitherapy:   pinterest powerpoint 10168